ALPHA CANCER THERAPY

Targeted conformal radiotherapy of disseminated cancers, using the alpha-particle emitting radionuclides astatine-211, bismuth-213 and actinium-225.

CoordinatorGOETEBORGS UNIVERSITET
Grant period2012-04-01 - 2014-11-01
Funding bodyEuropean Union
Call numberFP7-PEOPLE-2010-IEF
Grant number272348
IdentifierG:(EU-Grant)272348

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)